MedTrace Logo

Effects of DPP-4 Inhibition on Triglycerides

NCT01527747 · Status: SUSPENDED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-04-07

No results posted yet for this study

Summary

The purpose of this study is to test the effects of saxagliptin, a treatment for diabetes, on fasting and post-meal blood triglyceride (blood fat) levels.

Conditions

Interventions

DRUG

Saxagliptin

5 mg daily

Sponsors & Collaborators

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • P Barton Duell, MD · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2024-11-30
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01527747 on ClinicalTrials.gov